Amlodipine Besylate/Indapamide

苯磺酸氨氯地平/吲达帕胺

Report date: 2022/03/08 16:45:33

Base Information

Drug NameAmlodipine Besylate/Indapamide
Drug Alias NameAmlodipine Besylate+Indapamide苯磺酸氨氯地平+吲达帕胺吲达帕胺+苯磺酸氨氯地平Indapamide/Amlodipine BesylateIndapamide+Amlodipine Besylate +[7] 
ClassificationSmall molecules
Mechanisms of ActionSymporters inhibitorsVoltage-gated calcium channel blockers
TargetsVoltage-gated calcium channelSymporters
Therapy Area/IndicationsEssential HypertensionHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsYes IndapamideAmlodipine Besylate
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesLaboratoires Servier
China Registration ClassN/A

Develop Information

Active CompaniesLes Laboratoires Servier
Inactive CompaniesN/A
Active IndicationsHypertension
Inactive IndicationsEssential Hypertension

Other Information

ATC CodeN/A
Related LinksN/A